PAVmed(PAVM) - 2024 Q3 - Quarterly Results

Exhibit 99.1 PAVmed Provides Business Update and Third Quarter 2024 Financial Results Lucid reports record quarterly EsoGuardrevenue and completes clinical evidence package for imminent submission to formally seek Medicare coverage Veris Health completes pilot program with The Ohio State's James Cancer Hospital and continues pursuit of financing to relaunch development of implantable monitor Ongoing initiatives position PAVmed to preserve Nasdaq listing Conference call and webcast to be held today, November ...